In vitro evidence for estrogen receptor activity of selected phase II isoflavone metabolites
Archives of Toxicology · 2026-08 · 100 (8) · 3567-3582
DOI: 10.1007/s00204-026-04391-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Toxicology, online erschienen am 28.04.2026. Verfasst von Dino Grgic und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Food Chemistry and Toxicology, Faculty of Chemistry, University of Vienna, Währinger Str. 38-40, 1090, Vienna, Austria. Hauptthemen laut MEDLINE: Isoflavones, Estrogen Receptor beta, Estrogen Receptor alpha, Phytoestrogens. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Veterinary Medicine Vienna.
Abstract (Originalsprache)
The health benefits of soy and soy derived foods are often attributed to their isoflavone (ISFs) content, known to include phytoestrogens. However, EFSA has concluded that there is insufficient scientific evidence to establish a causal relationship between ISFs consumption and the proposed health claims. Although phase-II metabolites of ISFs are often considered as detoxified products with reduced estrogenic effects, recent studies indicate that ISFs metabolites may contribute and even enhance the biological activity of ISFs. However, current knowledge on phase-II metabolites of ISFs is limited, even though representing the major ISFs metabolites circulating in the bloodstreams in humans. This study investigates the role of phase-II metabolism in the biological activity of ISFs, focusing on estrogenicity and cytotoxicity in estrogen-sensitive Ishikawa cells (expressing estrogen receptors (ER) α and β). ISFs concentrations from 0.001 to 10 µM, with 1:10 dilution steps, were tested. Cleavage to parent compounds during incubation was also evaluated using high-performance liquid chromatography tandem mass spectrometry. The results showed that phase-II metabolites, particularly sulfates, can still exhibit estrogenic activity, challenging the general assumption that phase-II metabolism always leads to the inactivation of ISFs. In particular, at 10 µM daidzein-4'-sulfate exhibited a comparable estrogenic activity to daidzein at the same concentration, and genistein-7-sulfate exhibited estrogenic potential at higher concentrations. Molecular dynamics simulations revealed that genistein and its conjugates can stably interact with ERβ. This study highlights the importance of phase-II metabolism for ISFs activity and suggests that the sulfates formed should be examined more closely in further investigations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Food Chemistry and Toxicology, Faculty of Chemistry, University of Vienna, Währinger Str. 38-40, 1090, Vienna, Austria.
- Doctoral School in Chemistry, University of Vienna, Währinger Str. 38-40, 1090, Vienna, Austria.
- Department of Food and Drug, University of Parma, 43124, Parma, Italy.
- Department of Safety and Quality of Fruit and Vegetables, Max Rubner-Institut, Federal Research Institute of Nutrition and Food, Haid-Und-Neu-Straße 9, 76131, Karlsruhe, Germany.
- Department of Food Chemistry and Toxicology, Faculty of Chemistry, University of Vienna, Währinger Str. 38-40, 1090, Vienna, Austria. elisabeth.varga@vetmeduni.ac.at.
- Food Hygiene and Technology, Centre for Food Science, Clinical Department for Farm Animals and Food System Transformation, University of Veterinary Medicine, Veterinärplatz 1, 1210, Vienna, Austria. elisabeth.varga@vetm…
ORCID-Profile: Dino Grgic, Luca Dellafiora, Sabine E Kulling, Elisabeth Varga, Doris Marko
Förderung
- University of Veterinary Medicine Vienna
Zitieren
APA
Grgic, D., Bella-Velidou, D., Dellafiora, L., Soukup, S. T., Kulling, S. E., Varga, E., & Marko, D. (2026). In vitro evidence for estrogen receptor activity of selected phase II isoflavone metabolites. Archives of Toxicology, 100(8), 3567-3582. https://doi.org/10.1007/s00204-026-04391-2
Vancouver
Grgic D, Bella-Velidou D, Dellafiora L, Soukup ST, Kulling SE, Varga E, et al. In vitro evidence for estrogen receptor activity of selected phase II isoflavone metabolites. Archives of Toxicology. 2026;100(8):3567-3582. doi:10.1007/s00204-026-04391-2
BibTeX
@article{Grgic2026,
author = {Grgic, Dino and Bella-Velidou, Dimitra and Dellafiora, Luca and Soukup, Sebastian T and Kulling, Sabine E and Varga, Elisabeth and Marko, Doris},
title = {In vitro evidence for estrogen receptor activity of selected phase II isoflavone metabolites},
journal = {Archives of Toxicology},
year = {2026},
volume = {100},
number = {8},
pages = {3567--3582},
doi = {10.1007/s00204-026-04391-2}
}
EUVIMED